Suvretta Capital Management »

Medline shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Medline (MDLN) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Medline

Tip: Access up to 7 years of quarterly data

All positions including Medline held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Medline by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.8M 43k 42.00

More positions owned by Suvretta Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Arcutis Biotherapeutics (ARQT)
Ark Etf Tr Genomic Rev Etf Put Option (ARKG)
Benitec Biopharma Com New (BNTC)
Legend Biotech Corp Sponsored Ads (LEGN)
Eyepoint Com New (EYPT)
Arcus Biosciences Incorporated (RCUS)
Immatics SHS (IMTX)
Biohaven (BHVN)
Meta Platforms Cl A (META)
Apellis Pharmaceuticals (APLS)
NVIDIA Corporation (NVDA)
Coca-Cola Company (KO)
Ge Aerospace Com New (GE)
Amazon (AMZN)

View all positions for Suvretta Capital Management

Top funds holding Medline

Carlyle
H&F Corporate Investors X
Vanguard Group
Capital Research Global Investors
BlackRock
Baillie Gifford & Co
Massachusetts Financial Services
WCM Investment Management
T. Rowe Price Investment Management
Viking Global Investors
Durable Capital Partners
Norges Bank Investment Management
Artisan Partners Limited Partnership
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capital World Investors

View all funds holding Medline